Skip to main content
Our Products

Solutions designed for your unique needs

Comprehensive EDC Image

Comprehensive EDC

E-PatientReportedOutcomes

e-Patient Reported Outcomes

Study Designing  Image

Unified Trial Builder

Mobile Data Capture Image

Mobile Data Capture

Insights

We are thought leaders with 100+ clients in the pharmaceuticals, CRO and medical devices industries.

RISK-BASED MONITORING- The next revolution in Clinical trials

Articles

RISK-BASED MONITORING- The next revolution in Clinical trials

Effective monitoring of clinical trials is a critical step while conducting quality studies and safeguarding subjects.
View more
Patient centric trial design- The new success model

Whitepaper

Patient centric trial design- The new success model

The clinical trial industry is going through a tectonic shift when it comes to increasing trial cost, time to market drugs and focus on patient empowerment. Yet, the toughest challenge in success of a clinical trial is to retain patients. In this whitepaper, we explore the various best practices of retaining patients and having a collaborative relationship with them.
View more
Lupin Implements Acceliant Platform for BA/BE studies

Case Studies

Lupin Implements Acceliant Platform for BA/BE studies

Acceliant developed a robust platform with a best-of-breed interface for clinical studies of Lupin.
View more
From Our Blog
How You can Use Risk-Based Monitoring (RBM) to Boost Clinical Trial Outcomes

How You can Use Risk-Based Monitoring (RBM) to Boost Clinical Trial Outcomes

As the costs and complexity of clinical trials continue to rise substantially, study sponsors like you are increasingly spending more on monitoring...
Read More
Toward Faster and Cheaper Trials: Three Ways You can Improve Clinical Data Accuracy

Toward Faster and Cheaper Trials: Three Ways You can Improve Clinical Data Accuracy

Clinical trial complexity continues to grow with the number of procedures per protocol increasing significantly...
Read More
Building a Single, Connected Platform for EDC, Randomization and ePRO

Building a Single, Connected Platform for EDC, Randomization and ePRO

Leading pharma regulators such as the U.S. FDA continue to impose, and enforce, strict compliance standards with regard to approval of new drugs. The U.S. watchdog’s strict vigil means that for every…
Read More
Our Clients Love Us
Watch: How we add value

Want to know more? Talk to us.

Contact us+1-408-387-5800